DECIPHERA PHARMACEUTICALS IN (DCPH)

US24344T1016 - Common Stock

25.38  +0.02 (+0.08%)

After market: 25.38 0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
96.148M
128.45%		134.036M
39.41%		163.356M
21.87%		204.27M
25.05%
EBITDA
YoY % growth
-297.063M
-10.48%		-179.776M
39.48%		-208.858M
-16.18%		-206.04M
1.35%		N/AN/AN/AN/A
EBIT
YoY % growth
-300.077M
-10.65%		-182.722M
39.11%		-210.958M
-15.45%		-208.426M
1.20%
Operating Margin
-312.10%-136.32%-129.14%-102.03%
EPS
YoY % growth
-5.15
-7.52%		-2.55
50.49%		-2.29
10.20%		-2.21
3.71%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth		-0.56
7.23%
Revenue
Q2Q % growth		47.233M
41.23%
EBITDA
Q2Q % growth		-51MN/AN/AN/AN/A
EBIT
Q2Q % growth		-51.716M
2.89%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 -0.54
10.00%		-0.590.058.79%
Q3 2023
Q2Q % growth		 -0.58
-5.45%		-0.620.046.60%
Q2 2023
Q2Q % growth		 -0.57
5.00%		-0.630.069.87%
Q1 2023
Q2Q % growth		 -0.60
25.00%		-0.610.010.83%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 48.294M
32.88%		46.837M1.457M3.11%
Q3 2023
Q2Q % growth		 43.313M
20.40%		40.189M3.124M7.77%
Q2 2023
Q2Q % growth		 38.304M
17.88%		36.602M1.702M4.65%
Q1 2023
Q2Q % growth		 33.445M
14.45%		36.512M-3.067M-8.40%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0.17% 7.64% 1.78% 6.95%
Revenue0.29% 6.12% 0.21% 5.84%